Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2026-01-10 @ 4:09 AM
Study NCT ID:
NCT02879305
Status:
COMPLETED
Last Update Posted:
2021-12-03
First Post:
2016-08-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-22
First Submit QC Date:
None
Study First Post Date:
2016-08-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-11-05
Results First Submit QC Date:
None
Results First Post Date:
2021-12-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-05
Last Update Post Date:
2021-12-03
Last Update Post Date Type:
ACTUAL